Skip to main content
. 2016 Aug 15;5(8):e251. doi: 10.1038/oncsis.2016.54

Figure 2.

Figure 2

Patient outcome is associated with Src-pY416 expression. (a) Evaluating percentage of cells staining positive for active Src indicated a trend for poorer survival in Src-pY416 expressing tumors. (b) Staining intensity is associated with patient outcome, patients not expressing active Src have improved survival. (c) All expressing cases were compared with all negative cases; expression of active Src was associated with significantly shorter survival.